Gerstel GmbH & Co. KG (Mülheim an der Ruhr, Germany) and Spark Holland (Emmen, The Netherlands) have announced an original equipment manufacturer (OEM) agreement. The agreement will allow Gerstel to develop and market fully integrated automated dried blood spot (DBS) technology from Spark Holland that recently received a US patent. DBS or dried matrix sampling is an emerging tool for bioanalysis, and is particularly useful in the clinical and pharmaceutical laboratory, requiring 5–15 μL of sample for each analysis.
Ralf Bremer, Managing Director, R&D and Production, Gerstel, said: “Gerstel prides itself on being an innovative company led by the needs of our customers. We identified in Spark a complementary technical expertise and have already successfully integrated its SPE technology into our systems.”
Rob van der Knaap, President Spark Holland BV, commented: “We are delighted to be partnering with such an innovative technical company. We are especially pleased to sign the OEM agreement for our patented FTD technology with Gerstel and look forward to seeing the company deliver the first integrated DBS solutions.”